OpenEvidence scores $250M, doubles valuation to $12B

{
  "signal_id": "5d85b882-f595-4c7c-b450-589e1d50d626",
  "signal_type": "news",
  "signal_subtype": "receives_financing",
  "detected_at": "2026-01-21T00:00:00+00:00",
  "company": {
    "name": "OpenEvidence",
    "domain": "openevidence.com"
  },
  "data": {
    "url": "https://www.mobihealthnews.com/news/openevidence-scores-250m-doubles-valuation-12b",
    "title": "OpenEvidence scores $250M, doubles valuation to $12B",
    "amount": "$250 million",
    "excerpt": "OpenEvidence scores $250M, doubles valuation to $12B.\n\nThe investment brings the company's total raise to nearly $700 million.\n\nOpenEvidence, an AI-enabled medical research aggregate platform for doctors, has closed a $250 million Series D funding round, bringing its total raise to nearly $700 million over the past 12 months and doubling its valuation to $12 billion.\n\nThe company said previous investors include Sequoia, Google Ventures, NVIDIA, Kleiner Perkins, Blackstone, Henry Kravis, Coatue, Thrive Capital, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Craft Ventures, Goanna, Meritech, Alkeon, Mayo Clinic and others, and many of those entities also followed on in the Series D round.\n\nOpenEvidence is a free medical information platform that offers an AI-enabled medical copilot for doctors in the U.S. trained only on medical journals and medical data. It aggregates and synthesizes clinical information to help doctors make more evidence-based decisions.\n\nThe company's AI is trained on specialized content through strategic collaborations, including partnerships with the New England Journal of Medicine, the American Medical Association, the National Comprehensive Cancer Network and the American College of Cardiology.\n\nOpenEvidence will use the funds to invest in research and development and compute costs associated with its multi-AI agentic architecture.\n\n\"If a doctor...",
    "summary": "OpenEvidence received financing of $250M in Series D on Jan 21st '26.",
    "category": "receives_financing",
    "found_at": "2026-01-21T00:00:00Z",
    "location": "Miami, Florida, United States",
    "planning": false,
    "image_url": "https://www.mobihealthnews.com/sites/mhn/files/2026-01/web_16x9_lg-GettyImages-960093670.JPG",
    "confidence": 1,
    "published_at": "2026-01-21T00:00:00Z",
    "location_data": [
      {
        "city": "Miami",
        "state": "Florida",
        "country": "United States",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-01-21",
    "financing_type": "Series D",
    "article_sentence": "OpenEvidence, an AI-enabled medical research aggregate platform for doctors, has closed a $250 million Series D funding round, bringing its total raise to nearly $700 million over the past 12 months and doubling its valuation to $12 billion.",
    "amount_normalized": 250000000,
    "financing_type_tags": [
      "equity"
    ],
    "financing_type_normalized": "series_d"
  }
}

curl https://signals.autobound.ai/v1/signals/5d85b882-f595-4c7c-b450-589e1d50d626 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"openevidence.com","limit":20}'